Day CP - Search Results

1

Theophylline improves steroid sensitivity in acute alcoholic hepatitis.

Kendrick SF, Henderson E, Palmer J, Jones DE, Day CP. Kendrick SF, et al. Among authors: day cp. Hepatology. 2010 Jul;52(1):126-31. doi: 10.1002/hep.23666. Hepatology. 2010. PMID: 20578267 Clinical Trial.

2

Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis.

Reeves HL, Burt AD, Wood S, Day CP. Reeves HL, et al. Among authors: day cp. J Hepatol. 1996 Nov;25(5):677-83. doi: 10.1016/s0168-8278(96)80238-8. J Hepatol. 1996. PMID: 8938545 Clinical Trial.

3

Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis.

Grove J, Daly AK, Bassendine MF, Day CP. Grove J, et al. Among authors: day cp. Hepatology. 1997 Jul;26(1):143-6. doi: 10.1002/hep.510260119. Hepatology. 1997. PMID: 9214463

4

Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.

Smith BC, Gorve J, Guzail MA, Day CP, Daly AK, Burt AD, Bassendine MF. Smith BC, et al. Among authors: day cp. Hepatology. 1998 Jun;27(6):1695-9. doi: 10.1002/hep.510270631. Hepatology. 1998. PMID: 9620344

5

No evidence for involvement of the interleukin-10 -592 promoter polymorphism in genetic susceptibility to primary biliary cirrhosis.

Zappala F, Grove J, Watt FE, Daly AK, Day CP, Bassendine MF, Jones DE. Zappala F, et al. Among authors: day cp. J Hepatol. 1998 May;28(5):820-3. doi: 10.1016/s0168-8278(98)80232-8. J Hepatol. 1998. PMID: 9625317

6

Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance.

James OF, Day CP. James OF, et al. Among authors: day cp. J Hepatol. 1998 Sep;29(3):495-501. doi: 10.1016/s0168-8278(98)80073-1. J Hepatol. 1998. PMID: 9765002 Review. No abstract available.

7

Tumour necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosis.

Jones DE, Watt FE, Grove J, Newton JL, Daly AK, Gregory WL, Day CP, James OF, Bassendine MF. Jones DE, et al. Among authors: day cp. J Hepatol. 1999 Feb;30(2):232-6. doi: 10.1016/s0168-8278(99)80067-1. J Hepatol. 1999. PMID: 10068101

8

Alcoholic liver disease: new insights into mechanisms and preventative strategies.

Stewart S, Jones D, Day CP. Stewart S, et al. Among authors: day cp. Trends Mol Med. 2001 Sep;7(9):408-13. doi: 10.1016/s1471-4914(01)02096-2. Trends Mol Med. 2001. PMID: 11530336 Review.

9

Genetic and epigenetic factors in autoimmune reactions toward cytochrome P4502E1 in alcoholic liver disease.

Vidali M, Stewart SF, Rolla R, Daly AK, Chen Y, Mottaran E, Jones DE, Leathart JB, Day CP, Albano E. Vidali M, et al. Among authors: day cp. Hepatology. 2003 Feb;37(2):410-9. doi: 10.1053/jhep.2003.50049. Hepatology. 2003. PMID: 12540792

10

Pain as a complication of use of opiate antagonists for symptom control in cholestasis.

McRae CA, Prince MI, Hudson M, Day CP, James OF, Jones DE. McRae CA, et al. Among authors: day cp. Gastroenterology. 2003 Aug;125(2):591-6. doi: 10.1016/s0016-5085(03)00879-5. Gastroenterology. 2003. PMID: 12891561

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298 results

Search Page

Filters